Glutathione
Last reviewed September 26, 2026
Glutathione is a tripeptide antioxidant produced in every cell. Research examines its role in redox defense, detoxification pathways, and immune function, the last giving it a Foundation crossover.
Mechanism of action
Research describes glutathione cycling between reduced and oxidized states to neutralize reactive oxygen species, and acting as a substrate in phase II detoxification.
- Redox CyclingAlternates between reduced and oxidized forms to neutralize reactive species generated by normal metabolism.
- DetoxificationStudied as a conjugation substrate in the pathways that prepare compounds for clearance.
- Route studied
- Subcutaneous
- Research status
- Early clinical
Glutathione has been examined in small human randomized controlled trials of oral supplementation and skin pigmentation, alongside animal studies and reviews, but no phase 3 trials are indicated in the cited literature.
What the research covers
What research examines
- Redox defense and antioxidant activity
- Phase II detoxification pathways
- Body glutathione stores and immune function markers in human trials
- Skin pigmentation and melasma
- UVB-induced oxidative stress in animal models
- HIV-associated neurocognitive disorders (review)
Reported effects in studies
- Human safety data for subcutaneous use are limited
- Safety of glutathione for skin lightening has been examined in narrative and systematic reviews
- Reviews describe the skin-lightening evidence as mixed and subject to controversy
- Specific adverse event rates are not summarized in the cited studies
What research protocols have used
Research protocols have used 200–600 mg per administration, 3 times per week (morning). Reported cycle: continuous.
For research use only. These figures summarize published research protocols. They are not instructions or medical advice.
Every CoreX order ships with a per-lot protocol guide.
Open the reconstitution calculatorCited research
- Randomized controlled trial of oral glutathione supplementation on body stores of glutathione.
European journal of nutrition · 2015 · RCT · PubMed 24791752
- Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function.
European journal of clinical nutrition · 2018 · PubMed 28853742
- The effects of the oral supplementation of L-Cystine associated with reduced L-Glutathione-GSH on human skin pigmentation: a randomized, double-blinded, benchmark- and placebo-controlled clinical trial.
Journal of cosmetic dermatology · 2022 · RCT · PubMed 33834608
- Glutathione as a skin-lightening agent and in melasma: a systematic review.
International journal of dermatology · 2025 · Systematic review · PubMed 39444151
- Exploring the Safety and Efficacy of Glutathione Supplementation for Skin Lightening: A Narrative Review.
Cureus · 2025 · Review · PubMed 40013212
Questions about Glutathione
Glutathione is a tripeptide antioxidant produced in every cell. Research examines its role in redox defense, detoxification pathways, and immune function. It is categorized under longevity research and also has a Foundation crossover because of the immune function work. CoreX supplies glutathione for laboratory research use only, and the published literature includes cell, animal, and small human studies as well as several reviews.
Research describes glutathione cycling between reduced and oxidized states to neutralize reactive oxygen species generated by normal metabolism. It is also studied as a conjugation substrate in phase II detoxification, the pathways that prepare compounds for clearance from the body. These two roles, redox cycling and detoxification, form the basis of most mechanistic discussion of the molecule in the research literature.
Randomized controlled trials have examined whether oral glutathione, including a liposomal form, raises body stores of glutathione, and one study reported changes in markers of immune function. A substantial body of work has studied glutathione in skin pigmentation and melasma, including a controlled trial combining L-cystine with reduced glutathione. Animal research has examined UVB-induced melanogenesis and oxidative stress, and a review has discussed glutathione in HIV-associated neurocognitive disorders.
Human safety data for subcutaneous glutathione are limited. Narrative and systematic reviews have examined the safety and efficacy of glutathione supplementation for skin lightening, and one review frames the topic in terms of facts, myths, evidence, and controversies, indicating that conclusions remain mixed. Specific adverse event rates are not summarized in the cited studies, so the safety profile should be regarded as incompletely characterized.
Research protocols have used 200–600 mg per administration, 3 times per week in the morning, via the subcutaneous route, with a reported continuous cycle. These figures describe what has been used in research settings and are not recommendations. Each CoreX order ships with a protocol guide for laboratory reference. Oral human trials in the literature used different formulations, so results across routes are not directly comparable.
Ask about Glutathione
Our research assistant answers questions about the science, the studied ranges, and our products. It can be wrong, and it does not give medical advice.
Glutathione at CoreX
Every batch is independently tested for identity and purity, and the certificate of analysis is tied to the lot number on your label.
Longevity
$79.00









